Screening cutoff level in ng/mL for workplace urine cotinine tobacco biomarker test strips?
Short answer
Standard workplace urine cotinine test strips use a screening cutoff level of 200 ng/mL to detect active nicotine use. This threshold reliably separates active tobacco users from individuals exposed to passive secondhand smoke. The test detects cotinine for two to four days after tobacco or nicotine consumption, delivering visual results within five minutes to ensure accurate workplace policy compliance and fair wellness evaluations.
Standard workplace urine cotinine test strips utilize a screening cutoff level of 200 ng/mL to accurately distinguish active tobacco or nicotine consumption from passive environmental smoke exposure.
Workplace wellness programs and occupational health screening protocols require objective verification of non-tobacco status to manage insurance incentives and company policy compliance. Cotinine, the primary chemical metabolite created when the liver processes nicotine, remains detectable in urine for 2 to 4 days, providing a wider detection window than direct nicotine measurement.
If you only do one thing: Select rapid urine test strips calibrated to a 200 ng/mL cutoff threshold to avoid false positives caused by incidental secondhand smoke while reliably identifying active users.
- Standard screening threshold: Point-of-care immunoassay dip cards calibrate to 200 ng/mL (nanograms per milliliter, a standard laboratory measurement of fluid concentration) as the baseline for active tobacco use.
- Alternative sensitivity cutoffs: Specialized clinical strips feature thresholds at 100 ng/mL for strict cessation monitoring or 500 ng/mL to screen specifically for moderate-to-heavy daily combustible tobacco use.
- Detection window: Cotinine metabolic clearance delivers a reliable urine testing window of 48 to 96 hours following cigarette, vape, pouch, or nicotine replacement therapy use.
- Visual result timing: Lateral flow qualitative test strips deliver negative or presumptive positive visual results within 5 minutes at room temperature between 15°C and 30°C.
- Secondary confirmation standard: Presumptive positive rapid immunoassay screens require Gas Chromatography-Mass Spectrometry (GC-MS) laboratory testing with a 50 ng/mL confirmation threshold for formal verification.
- Watch out for: Nicotine replacement therapies like gums, patches, and lozenges generating positive cotinine results indistinguishable from smoking on standard immunoassay strips.
- Watch out for: Reading faint test lines as positive, because any visible test line on competitive lateral flow assays indicates a negative result below the 200 ng/mL mark.
- Watch out for: Specimen dilution from high fluid intake reducing urine creatinine levels below 20 mg/dL, which can push cotinine levels below the detection threshold.
Match your workplace policy specifications to CLIA-waived 200 ng/mL cotinine test panels for standard point-of-care screening. For personal health decisions, clinical smoking cessation protocols, or contested employment tests, consult a licensed healthcare professional or certified Medical Review Officer.